The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Matrix metalloproteinase-23 as a new immunotherapeutic checkpoint target in melanoma.
Duane Moogk
No relevant relationships to disclose
Michelle W. Ma
No relevant relationships to disclose
Ines Esteves Domingues Pires Da Silva
No relevant relationships to disclose
Erica Brooke Friedman
No relevant relationships to disclose
Eleazar Vega-Saenz de Miera
No relevant relationships to disclose
Farbod Darvishian
No relevant relationships to disclose
Arianne Perez-Garcia
No relevant relationships to disclose
Patrick Scanlon
No relevant relationships to disclose
Anna C. Pavlick
No relevant relationships to disclose
Nina Bhardwaj
No relevant relationships to disclose
Paul J. Christos
No relevant relationships to disclose
Iman Osman
No relevant relationships to disclose
Michelle Krogsgaard
No relevant relationships to disclose